Parathyroid Scintigraphy

Posted by Dr. Rutuja Kote on Fri, Dec 30, 2022
  • The parathyroid glands are able to concentrate a variety of chemical substances.
  • Tc99m sestamibi is the most commonly used agent.
  • Works on differential washout of MIBI from thyroid and parathyroid gland.
  • Single isotope- double phase technique
  • MIBI washes out early from the thyroid gland compared to parathyroid gland.
  • Retention is proportional to number of oxyphil cells.
  • Physiological uptake noted in thyroid gland, heart, liver, salivary gland.

Image

Protocol

  • Single injection of 20-30mCi of Tc99m Sestamibi given I.V.
  • Planer image is taken at 15 minutes (early) and 1.5 to 3 hours later (late)
  • Followed by SPECT or SPECT/CT for each time.
  • Thyroid scan with Tc99m pertechnetate is done
  • Chest/whole body survey is done to look for ectopic lesion/ brown tumour.
  • Subtraction images are taken and compared
  • A persistent focus of activity, in delayed images, relative to the thyroid gland activity, indicative of the parathyroid lesion.

Image

Advantages:

  • Relatively operator independent in comparison with USG
  • Detects ectopic and posterior glands that USG may miss
  • Provide valuable anatomic landmark
  • Lower radiation dose than with 4D CT
  • Can we used as a tool in operating room for parathyroid localization- Radio guided parathyroidectomy.

Limitations:

  • Patients must remain relatively motionless for a longer period of time
  • More expensive than USG and 4D-CT scans
  • Scintigraphy perform poorly at detecting small glands (<300mg), multi-gland disease (<50% sensitivity)
  • Subtypes with fewer oxyphil cells do not take up tracer
  • Sometimes parathyroid carcinoma, thyroid nodules, thyroid malignancy lymph adenopathy can also mimic these findings.